肠道菌群
肝细胞癌
医学
治疗方式
癌变
免疫学
癌症
癌症研究
内科学
作者
Chuanjun Huang,Si Mei,Xue Zhang,Xuefei Tian
标识
DOI:10.1097/mcg.0000000000001883
摘要
Hepatocellular carcinoma (HCC) is an invasive primary liver cancer caused by multiple pathogenic factors and is a significant global health concern. With few effective therapeutic options, HCC is a heterogeneous carcinoma that typically arises in an inflammatory environment. Recent studies have suggested that dysbiotic gut microbiota is involved in hepatocarcinogenesis via multiple mechanisms. In this review, we discuss the effects of gut microbiota, microbial components, and microbiota-derived metabolites on the promotion and progression of HCC by feeding a persistent inflammatory milieu. In addition, we discuss the potential therapeutic modalities for HCC targeting the inflammatory status induced by gut microbiota. A better understanding of the correlation between the inflammatory milieu and gut microbiota in HCC may be beneficial for developing new therapeutic strategies and managing the disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI